JOHNSON & JOHNSON
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation NJ
Business Address ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Mailing Address ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
Phone 732-524-2455
Fiscal Year End 1228
EIN 221024240
Financial Overview
FY2025
$35.15B
Net Income
$24.11B
Cash & Equivalents
$13.88
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 13F-HR Institutional investment holdings | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 10-K Annual financial report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
Annual Reports
10-K February 11, 2026
- Strong operational revenue growth of 6.5% to $85.2 billion, driven by Pharmaceuticals and MedTech.
- Successful Kenvue spin-off sharpened strategic focus on high-growth Pharmaceuticals and MedTech segments.
Insider Trading
SELL 2 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.